Nationales Centrum für Tumorerkrankungen Dresden (NCT/UCC)
About Nationales Centrum für Tumorerkrankungen Dresden (NCT/UCC)
At the National Center for Tumor Diseases, patients and researchers walk through the same door. This is more than just a symbol: The NCT/UCC Dresden has set itself the task of linking research and patient care as closely as possible. This means that cancer patients in Dresden can be treated at the cutting edge of scientific knowledge, which is only possible in this form at a few university locations in Europe. The NCT/UCC Dresden is supported by the German Cancer Research Center Heidelberg, the Medical Faculty of the Technical University of Dresden, the University Hospital Carl Gustav Carus Dresden and the Helmholtz-Zentrum Dresden-Rossendorf. The Dresden site receives annual funding of 15 million euros, which is financed in a 90:10 ratio by the federal government and the Free State of Saxony. In addition, the Free State of Saxony is providing 22 million euros for the construction of a new NCT/UCC building on the grounds of the University Hospital. From 2020, the new NCT/UCC building will house a unique research platform with an operating theater of the future, laboratories, areas for patient studies and rooms for drug treatments and radiotherapy.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
- Industry : Healthcare